Breastcancer
101 – 110 of 117
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Apo-lipoproteins, lipids and risk of cancer.
(
- Contribution to journal › Article
-
Mark
Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study
(
- Contribution to journal › Article
-
Mark
High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancer
(
- Contribution to journal › Article
- 2015
-
Mark
The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.
(
- Contribution to journal › Article
-
Mark
Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial.
(
- Contribution to journal › Article
-
Mark
Effects of statin use on volumetric mammographic density: results from the KARMA study.
(
- Contribution to journal › Article
-
Mark
Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-based Prospective Cohort.
(
- Contribution to journal › Article
-
Mark
Global transcriptional changes following statin treatment in breast cancer.
(
- Contribution to journal › Article
-
Mark
Mammographic density in relation to tumor biomarkers, molecular subtypes, and mode of detection in breast cancer.
(
- Contribution to journal › Article
- 2014
-
Mark
Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort.
(
- Contribution to journal › Article